当前位置： SCI文献检索 > Cancer Genomics & Proteomics期刊下所有文献 > Association of BIM Deletion Polymorphism and BIM-γ RNA Expression in NSCLC with EGFR Mutation.

Association of BIM Deletion Polymorphism and BIM-γ RNA Expression in NSCLC with EGFR Mutation.

Abstract：

AIM:This pilot study assessed the association of BIM deletion polymorphism and BIM RNA isoform in patients with EGFR-positive non-small cell lung cancer (NSCLC). PATIENTS AND METHODS:The study included 33 patients with EGFR-positive NSCLC treated with gefitinib. BIM deletion polymorphism and BIM RNA isoform (EL/L/S/γ) were determined by polymerase chain reaction (PCR). RESULTS:BIM-γ expression was significantly higher in patients with BIM deletion polymorphism than among those without BIM deletion polymorphism inside tumors (p=0.038) and around tumors (p=0.0024). Relative BIM-γ expression was significantly higher in patients with BIM deletion polymorphism than among those without BIM deletion polymorphism (p=0.0017). Patients with BIM-γ had significantly shorter progression-free survival than those without BIM-γ (median: 304 vs. 732 days; p=0.023). CONCLUSION:Expression of BIM-γ mRNA and BIM deletion polymorphism were strongly associated. BIM-γ overexpression may have a role in apoptosis related to EGFR-tyrosine kinase inhibitor.

journal_name

Cancer Genomics Proteomics

journal_title

Cancer genomics & proteomics

authors

Isobe K,Kakimoto A,Mikami T,Kaburaki K,Kobayashi H,Yoshizawa T,Makino T,Otsuka H,Sano GO,Sugino K,Sakamoto S,Takai Y,Tochigi N,Iyoda A,Homma S

doi

10.21873/cgp.20010

subject

Has Abstract

pub_date

2016-01-01 00:00:00

pages

475-482

issue

6

eissn

1109-6535

issn

1790-6245

pii

13/6/475

journal_volume

13

pub_type

杂志文章

相关文献

Cancer Genomics & Proteomics文献大全
  • Lung Cancer Protein Expression Profiles of Smokers and Non-Smokers.

    abstract：:Epidemiological studies have established a causal relationship between cigarette smoking and respiratory tract cancer. The knowledge about the interaction of tobacco constituents with cellular systems is, however, still incomplete. Therefore, we analyzed 36 factors with known or assumed relevance and found that 8 prot...

    journal_title：Cancer genomics & proteomics

    pub_type： 杂志文章

    doi：

    authors： Efferth T,Koomägi R,Mattern J,Volm M

    更新日期：2004-05-01 00:00:00

  • Interpreting microarray data: towards the complete bioinformatics toolkit for cancer.

    abstract：:Functional genomics has been applied in the study of human malignancies since the inception of this field nearly a decade ago. Microarray analysis has been specifically used in an attempt to re-classify carcinomas at the molecular level, to aid in diagnosis/prognosis and to predict how various types of tumour respond ...

    journal_title：Cancer genomics & proteomics

    pub_type： 杂志文章

    doi：

    authors： Roberts ML,Kottaridis SD

    更新日期：2007-07-01 00:00:00

  • Fusion of the Genes WWTR1 and FOSB in Pseudomyogenic Hemangioendothelioma.

    abstract：BACKGROUND/AIM:Pseudomyogenic hemangioendothelioma is a rare endothelial tumor. Previous genetic investigations have shown that the tumors carry either a SERPINE1-FOSB or an ACTB-FOSB fusion gene. The aim of the study was to identify FOSB fusions linked with pseudomyogenic hemangioendothelioma. MATERIALS AND METHODS:R...

    journal_title：Cancer genomics & proteomics

    pub_type： 杂志文章

    doi：10.21873/cgp.20134

    authors： Panagopoulos I,Lobmaier I,Gorunova L,Heim S

    更新日期：2019-07-01 00:00:00

  • Comparison of Benign and Malignant Pilomatricomas Using Whole-exome Sequencing.

    abstract：BACKGROUND:Malignant pilomatricoma (MP) is a rare cancer of the hair matrix with only a few cases reported in literature. Given the rarity of this cancer and the lack of relevant genetic data, very little is known about the nature of the molecular pathophysiology except the involvement of the Catenin Beta 1 (CTNNB1)/Wn...

    journal_title：Cancer genomics & proteomics

    pub_type： 杂志文章

    doi：10.21873/cgp.20233

    authors： Yeo MK,Bae GE

    更新日期：2020-11-01 00:00:00

  • Evaluation of the Insulin-like Growth Factor Receptor Pathway in Patients with Advanced Breast Cancer Treated with Trastuzumab.

    abstract：BACKGROUND:Trastuzumab is a monoclonal antibody against HER2-positive breast cancer. Despite improving the natural history of the disease, there is a number of patients who are resistant to it, whereas all patients will eventually develop resistance and disease will progress. Inconsistent preclinical data show that the...

    journal_title：Cancer genomics & proteomics

    pub_type： 杂志文章

    doi：10.21873/cgp.20105

    authors： Christodoulou C,Oikonomopoulos G,Koliou GA,Kostopoulos I,Kotoula V,Bobos M,Pentheroudakis G,Lazaridis G,Skondra M,Chrisafi S,Koutras A,Bafaloukos D,Razis E,Papadopoulou K,Papakostas P,Kalofonos HP,Pectasides D,Skarlos P

    更新日期：2018-11-01 00:00:00

  • Genome-wide expression profiling reveals new insights into pathogenesis and progression of testicular germ cell tumors.

    abstract：:Testicular germ cell tumors (GCT) are the most frequent malignancy in young adults and arise from intratubular germ cell neoplasia undetermined (IGCNU, also referred to as carcinoma in situ, CIS). To determine the transcriptional programs involved in the transition from normal germ cells to GCT, and to further elucida...

    journal_title：Cancer genomics & proteomics

    pub_type： 杂志文章

    doi：

    authors： Biermann K,Heukamp LC,Steger K,Zhou H,Franke FE,Sonnack V,Brehm R,Berg J,Bastian PJ,Muller SC,Wang-Eckert L,Buettner R

    更新日期：2007-09-01 00:00:00

  • Breast cancer metastasis.

    abstract：:Breast cancer metastasis accounts for the majority of deaths from breast cancer. Detection of breast cancer metastasis at the earliest stage is important for the management and prediction of breast cancer progression. Emerging techniques using the analysis of circulating tumor cells show promising results in predictin...

    journal_title：Cancer genomics & proteomics

    pub_type： 杂志文章,评审

    doi：

    authors： Scully OJ,Bay BH,Yip G,Yu Y

    更新日期：2012-09-01 00:00:00

  • Identification of Endogenous Controls for Use in miRNA Quantification in Human Cancer Cell Lines.

    abstract：BACKGROUND:miRNAs play important roles in multiple biological processes, and deregulation has been linked to several human diseases, including cancer. Studying changes in miRNA expression in cancer development is commonly performed in vitro in human cancer cell lines using quantitative polymerase chain reaction (qPCR),...

    journal_title：Cancer genomics & proteomics

    pub_type： 杂志文章

    doi：

    authors： DAS MK,Andreassen R,Haugen TB,Furu K

    更新日期：2016-01-01 00:00:00

  • A Comprehensive Method for Detecting Fusion Genes in Paediatric Brain Tumours.

    abstract：BACKGROUND:Fusion genes driving tumourigenesis have drawn the attention of researchers and oncologists. Despite the importance of such molecular alterations, there are no comprehensive reproducible methods for detecting fusion genes. MATERIALS AND METHODS:Nineteen paediatric brain tumours of five types, namely pilocyt...

    journal_title：Cancer genomics & proteomics

    pub_type： 杂志文章

    doi：10.21873/cgp.20093

    authors： Kondo A,Shimizu Y,Adachi S,Ogino I,Suzuki M,Akiyama O,Arai H

    更新日期：2018-07-01 00:00:00

  • Galectin-3 expression in human papillary thyroid carcinoma.

    abstract：:Previous studies have suggested that galectin-3 expression was markedly elevated in papillary thyroid carcinoma compared to other thyroid diseases. In order to better understand this protein, galectin-3 from papillary thyroid carcinoma was partially purified by affinity chromatography on lactose-agarose. Proteins elut...

    journal_title：Cancer genomics & proteomics

    pub_type： 杂志文章

    doi：

    authors： Sawangareetrakul P,Srisomsap C,Chokchaichamnankit D,Svasti J

    更新日期：2008-03-01 00:00:00

  • Tyrosine kinase-deficient EphB6 receptor-dependent alterations in proteomic profiles of invasive breast carcinoma cells as determined by difference gel electrophoresis.

    abstract：:The expression profiles of the erythropoietin producing hepatocellular carcinoma (Eph) receptor family of tyrosine kinases have been previously shown to provide molecular signatures of normal breast cells, breast tumor cells and invasive breast carcinoma cells. In particular, the expression of EphB6 receptor is lost i...

    journal_title：Cancer genomics & proteomics

    pub_type： 杂志文章

    doi：

    authors： Kandpal RP

    更新日期：2010-09-01 00:00:00

  • Proteomic Profile of Sorafenib Resistance in Hepatocellular Carcinoma; GRP78 Expression Is Associated With Inferior Response to Sorafenib.

    abstract：BACKGROUND/AIM:The outcome of patients with advanced hepatocellular carcinoma (HCC) remains poor and therapeutic options, including sorafenib, the first anti-cancer drug proved to prolong survival in patients with advanced HCC, are limited. However, no clinically useful predictive biomarker for sorafenib has been repor...

    journal_title：Cancer genomics & proteomics

    pub_type： 杂志文章

    doi：10.21873/cgp.20159

    authors： Feng YH,Tung CL,Su YC,Tsao CJ,Wu TF

    更新日期：2019-11-01 00:00:00

  • Modulation of apoptosis protein profiles--role of P-gp in HeLa cells exposed to doxorubicin.

    abstract：:As shown previously doxorubicin (1 μM) plus sulindac (50 μM) reduced the expression of ABCB1 (ATP-binding cassette, sub-family B (MDR/TAP), member 1) mRNA in HeLa cells and this effect was accompanied by increased apoptosis. The aim of this study was to define if the decrease of ABCB1 expression or blocking of P-glyco...

    journal_title：Cancer genomics & proteomics

    pub_type： 杂志文章

    doi：

    authors： Gruber BM,Krzysztoń-Russjan J,Bubko I,Koronkiewicz M,Anuszewska EL

    更新日期：2012-05-01 00:00:00

  • A Proteomic Analysis of the Malignant Mesothelioma Secretome Using iTRAQ.

    abstract：:Backgound/Aim: Malignant mesothelioma (MM) is an aggressive and fatal pleural cancer. The cell secretome offers information allowing insight into the pathogenesis of MM while offering the possibility to identify potential therapeutic targets and biomarkers. In the present study the secretome protein profile of MM cell...

    journal_title：Cancer genomics & proteomics

    pub_type： 杂志文章

    doi：10.21873/cgp.20023

    authors： Creaney J,Dick IM,Leon JS,Robinson BW

    更新日期：2017-03-01 00:00:00

  • Low Levels of Microsatellite Instability at Simple Repeated Sequences Commonly Occur in Human Hepatocellular Carcinoma.

    abstract：BACKGROUND/AIM:The aim of this study was to assess the incidence of MSI in a large series of human hepatocellular carcinomas (HCC) with various etiologies. MATERIALS AND METHODS:The MSI status was determined by polymerase chain reaction (PCR) using 5 mononucleotide and 13 CAn dinucleotide repeats. RESULTS:None of the...

    journal_title：Cancer genomics & proteomics

    pub_type： 杂志文章

    doi：10.21873/cgp.20043

    authors： Goumard C,Desbois-Mouthon C,Wendum D,Calmel C,Merabtene F,Scatton O,Praz F

    更新日期：2017-09-01 00:00:00

  • The Role of micro RNAs in Breast Cancer Metastasis: Preclinical Validation and Potential Therapeutic Targets.

    abstract：:Despite the approval of several molecular therapies in the last years, breast cancer-associated death ranks as the second highest in women. This is due to metastatic disease, which represents a challenge for treatment. A better understanding of the molecular mechanisms of metastasis is, therefore, of paramount importa...

    journal_title：Cancer genomics & proteomics

    pub_type： 杂志文章,评审

    doi：10.21873/cgp.20062

    authors： Weidle UH,Dickopf S,Hintermair C,Kollmorgen G,Birzele F,Brinkmann U

    更新日期：2018-01-01 00:00:00

  • Proteomic identification of chaperonin-containing tail-less complex polypeptide-1 gamma subunit as a p53-responsive protein in colon cancer cells.

    abstract：:We recently reported that functional loss of p53 altered the responses of human HCT116 colon cancer cells to apoptosis triggers. To examine the molecular basis underlying the differential responses to drug treatment in the cancer cells, we performed a proteomic analysis in order to compare the protein expressions betw...

    journal_title：Cancer genomics & proteomics

    pub_type： 杂志文章

    doi：

    authors： Lee SC,Chan J

    更新日期：2012-03-01 00:00:00

  • Expression Analysis for the Identification of Genes Involved in Acquired Resistance to Cisplatin in Osteosarcoma Cells.

    abstract：BACKGROUND:Clinical observations indicate that tumour cells can acquire tolerance when an anticancer drug is administered repeatedly. In the present study, the gene expression in cisplatin-resistant cells was analysed to identify early changes in gene expression in the course of cisplatin exposure. MATERIALS AND METHO...

    journal_title：Cancer genomics & proteomics

    pub_type： 杂志文章

    doi：

    authors： Takazawa K,Tsuchiya H,Yoshimichi U,Kanazawa Y,Ii S,Tomita K

    更新日期：2006-11-01 00:00:00

  • Combination of a STAT3 Inhibitor and an mTOR Inhibitor Against a Temozolomide-resistant Glioblastoma Cell Line.

    abstract：BACKGROUND:Temozolomide-resistant (TMZ-R) glioblastoma is very difficult to treat, and a novel approach to overcome resistance is needed. MATERIALS AND METHODS:The efficacy of a combination treatment of STAT3 inhibitor, STX-0119, with rapamycin was investigated against our established TMZ-resistant U87 cell line. RES...

    journal_title：Cancer genomics & proteomics

    pub_type： 杂志文章

    doi：10.21873/cgp.20021

    authors： Miyata H,Ashizawa T,Iizuka A,Kondou R,Nonomura C,Sugino T,Urakami K,Asai A,Hayashi N,Mitsuya K,Nakasu Y,Yamaguchi K,Akiyama Y

    更新日期：2017-01-02 00:00:00

  • The Clinical Relevance of Frequent Germline Genetic Variants Detected by Targeted Sequencing in Patients With Rectal Adenocarcinoma (READ).

    abstract：BACKGROUND:The progression of colorectal cancer (CRC) mainly stems from the occurrence of somatic mutation. However, there is little information that can be used to comprehensively analyse the importance of germline variants in CRC patients. PATIENTS AND METHODS:The candidate germline variants between tumor relapse an...

    journal_title：Cancer genomics & proteomics

    pub_type： 杂志文章

    doi：10.21873/cgp.20189

    authors： Huang KC,Chiang SF,Ke TW,Chen WT,Chen TW,Chao KC

    更新日期：2020-05-01 00:00:00

  • Pull-down Assay on Streptavidin Beads and Surface Plasmon Resonance Chips for SWATH-MS-based Interactomics.

    abstract：BACKGROUND/AIM:Pul-down assay is a popular in vitro method for identification of physical interactors of selected proteins. Here, for the first time, we compared three conventional variants of pull-down assay with the streptavidin-modified surface plasmon resonance (SPR) chips for the detection of PDZ and LIM domain pr...

    journal_title：Cancer genomics & proteomics

    pub_type： 杂志文章

    doi：10.21873/cgp.20098

    authors： Maryáš J,Faktor J,Čápková L,Müller P,Skládal P,Bouchal P

    更新日期：2018-09-01 00:00:00

  • Significant Association Between the MiR146a Genotypes and Susceptibility to Childhood Acute Lymphoblastic Leukemia in Taiwan.

    abstract：BACKGROUND/AIM:Mounting evidence has shown that miRNAs play a critical role in the regulation of hematopoiesis of cell proliferation and apoptosis as well as in tumorigenesis. The miR146a rs2910164 polymorphism, which is closely responsive for its expression, has been reported to associate with the risk of several soli...

    journal_title：Cancer genomics & proteomics

    pub_type： 杂志文章

    doi：10.21873/cgp.20178

    authors： Pei JS,Chang WS,Hsu PC,Chen CC,Chin YT,Huang TL,Hsu YN,Kuo CC,Wang YC,Tsai CW,Gong CL,Bau DT

    更新日期：2020-03-01 00:00:00

  • Proteomic Analysis Reveals Aberrant O-GlcNAcylation of Extracellular Proteins from Breast Cancer Cell Secretion.

    abstract：BACKGROUND:O-GlcNAcylation is a unique intracellular protein modification; however, few extracellular O-GlcNAc-modified proteins have been discovered. We have previously demonstrated that many cellular proteins were aberrant in O-GlcNAcylation in breast cancer tissues. In the present study, therefore, we investigated w...

    journal_title：Cancer genomics & proteomics

    pub_type： 杂志文章

    doi：

    authors： Netsirisawan P,Chokchaichamnankit D,Srisomsap C,Svasti J,Champattanachai V

    更新日期：2015-07-01 00:00:00

  • Opposite Prognostic Impact of Single PTEN-loss and PIK3CA Mutations in Early High-risk Breast Cancer.

    abstract：BACKGROUND/AIM:PTEN-loss and PIK3CA mutations have been addressed as markers of PI3K activation in breast cancer. We evaluated these markers in early high-risk breast cancer (EBC) focusing on PTEN immunohistochemistry (IHC) issues, particularly in HER2-positive disease. MATERIALS AND METHODS:We examined PTEN-loss and ...

    journal_title：Cancer genomics & proteomics

    pub_type： 杂志文章

    doi：10.21873/cgp.20125

    authors： Lazaridis G,Kotoula V,Vrettou E,Kostopoulos I,Manousou K,Papadopoulou K,Giannoulatou E,Bobos M,Sotiropoulou M,Pentheroudakis G,Efstratiou I,Papoudou-Bai A,Psyrri A,Christodoulou C,Gogas H,Koutras A,Timotheadou E,Pectasi

    更新日期：2019-05-01 00:00:00

  • Cigarette smoke-induced effects on the cell cycle in oral cancer cells: reduction of G2/M fraction.

    abstract：BACKGROUND:Cigarette smoke (CS) is the main inducer of oral cancer, increasing its prevalence by 4-7 times. MATERIALS AND METHODS:We examined the suitability of cell models SCC-25 and SCC-15 for studying effects of CS on oral cancer cells and whether CS significantly affects the cell cycle using fluorescence-activated...

    journal_title：Cancer genomics & proteomics

    pub_type： 杂志文章

    doi：

    authors： Krayzler E,Nagler RM

    更新日期：2015-03-01 00:00:00

  • Prediction of Drug Sensitivity and Resistance of Cancer by Protein Expression Profiling.

    abstract：:Although the statistical probability of therapeutic success is known for larger groups of cancer patients, the clinical response to chemotherapy of the individual patient remains uncertain. It would be of great value to know whether or not an individual tumor responds to the proposed therapy. The concept of sensitivit...

    journal_title：Cancer genomics & proteomics

    pub_type： 杂志文章,评审

    doi：

    authors： Volm M,Koomagi R,Efferth T

    更新日期：2004-03-01 00:00:00

  • Inhibition of mTOR Activates the MAPK Pathway in Glioblastoma Multiforme.

    abstract：:Tumorigenesis of glioblastoma multiforme (GBM), the most aggressive primary intracranial neoplasm, is associated with aberrant PI3K/AKT/mTOR signaling. Inhibitors of mTOR, such as rapamycin (RAPA) or its analogs, have provided limited benefit. Here, we aim to decipher the signaling pathways involved in RAPA resistance...

    journal_title：Cancer genomics & proteomics

    pub_type： 杂志文章

    doi：

    authors： Albert L,Karsy M,Murali R,Jhanwar-Uniyal M

    更新日期：2009-09-01 00:00:00

  • Keratinocyte Growth Factor-Mediated Pattern of Gene Expression in Breast Cancer Cells.

    abstract：BACKGROUND:Breast cancer metastasis is associated with the motility and invasiveness of breast cancer cells. In a previous study we reported the motility enhancement effect of keratinocyte growth factor (KGF) on breast cancer cells. This study established and characterized the influence of KGF on breast cancer cell mot...

    journal_title：Cancer genomics & proteomics

    pub_type： 杂志文章

    doi：

    authors： Zang XP,Lerner ML,DO SV,Brackett DJ,Pento JT

    更新日期：2004-07-01 00:00:00

  • Concurrent down-regulation of Egr-1 and gelsolin in the majority of human breast cancer cells.

    abstract：UNLABELLED:A growing body of evidence suggests that early growth response-1 (Egr-1), a transcription factor, may function as a tumor suppressor. The aim of this study was to gain more evidence to support the role of Egr-1 in the suppression of cancer cell growth and to examine the potential correlation between Egr-1 an...

    journal_title：Cancer genomics & proteomics

    pub_type： 杂志文章

    doi：

    authors： Liu J,Liu YG,Huang R,Yao C,Li S,Yang W,Yang D,Huang RP

    更新日期：2007-11-01 00:00:00

  • Therapy-, gender- and race-specific microRNA markers, target genes and networks related to glioblastoma recurrence and survival.

    abstract：AIM:To identify and study targets of microRNA biomarkers of glioblastoma survival across events (death and recurrence) and phases (life expectancy or post-diagnostic) using functional and network analyses. MATERIALS AND METHODS:microRNAs associated with glioblastoma survival within and across race, gender, recurrence,...

    journal_title：Cancer genomics & proteomics

    pub_type： 杂志文章

    doi：

    authors： Delfino KR,Serão NV,Southey BR,Rodriguez-Zas SL

    更新日期：2011-07-01 00:00:00